✦ LIBER ✦

Long term rivastigmine treatment produces persistent inhibition of acetyl- and butyrylcholinesterase activity in CSF of Alzheimer's patients

✍ Scribed by Darreh-Shori, Taher; Svensson, Anne-Lie; Nordberg, Agneta

Book ID: 121981338
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 187 KB
Volume: 21
Category: Article
ISSN: 0197-4580
DOI: 10.1016/S0197-4580(00)83431-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in CSF acetyl- and butyrylcholin

Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer’s disease

✍ L. Parnetti; D. Chiasserini; U. Andreasson; M. Ohlson; C. Hüls; H. Zetterberg; L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

Long-Term Effects of Rivastigmine Treatm

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimer’s Disease

✍ Keith Edwards, Barbara Koumaras, Michael Chen, Ibrahim Gunay, Dr Dario Mirski 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 115 KB

Long-term effect of phenserine treatment

Long-term effect of phenserine treatment in Alzheimer patients as assessed by PET and CSF biomarkers

✍ Ahmadul Kadir; Henrik Zetterberg; Niels Andreasen; Ove Almkvist; Anders Wall; An 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Long-term treatment with selegiline decr

Long-term treatment with selegiline decreases the CSF concentration of amyloid precursor protein in patients with Alzheimer's disease

✍ Durrleman, Stephanie 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Inhibition of acetyl- and butyryl-cholin

Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit

✍ E. Giacobini; R. Spiegel; A. Enz; A. E. Veroff; N. R. Cutler 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 169 KB

579 Efficacy and safety of selegiline in

579 Efficacy and safety of selegiline in the long-term treatment of patients with Alzheimer's disease

✍ P.J. Riekkinen Sr; K. Koivisto; E.-L. Helkala; T. Hänninen; K.J. Reinikainen; O. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 169 KB